Generic antibiotic industries: Challenges and implied strategies with regulatory perspectives
2011
Challenges and Strategies in Generic Antibiotic Industries
publication
Evidence: moderate
Author Information
Author(s): Venkatesh M., Bairavi V. G., Sasikumar K. C.
Primary Institution: Orchid Chemicals & Pharmaceuticals Ltd.
Conclusion
The review highlights the complexities and regulatory challenges faced by generic antibiotic industries while emphasizing their importance in public health.
Supporting Evidence
- Antibiotics have significantly reduced the occurrences of diseases like diphtheria and syphilis.
- The USA market is a major target for generic pharmaceutical manufacturers due to its potential.
- Generic antibiotics can lead to substantial cost savings for consumers.
Takeaway
This article talks about how generic antibiotics help people by being cheaper and more available, but there are many rules and challenges that make it hard for companies to make them.
Methodology
The article reviews the history, regulations, and market dynamics of generic antibiotics.
Limitations
The review may not cover all aspects of the global antibiotic market and regulatory challenges.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website